Zi Yun Dong Fang’s IPO valuation is extremely rich, with P/S and EV/EBIT multiples far exceeding established consulting peers ...

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today ...